BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15729374)

  • 1. Erectile dysfunction in patients with coronary artery disease.
    Kloner R; Padma-Nathan H
    Int J Impot Res; 2005; 17(3):209-15. PubMed ID: 15729374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
    Jackson G; Montorsi P; Cheitlin MD
    Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA; Satyanarayana R
    Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile dysfunction therapy in special populations and applications: coronary artery disease.
    DeBusk RF
    Am J Cardiol; 2005 Dec; 96(12B):62M-66M. PubMed ID: 16387570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of erectile dysfunction. Hard facts support sildenafil].
    MMW Fortschr Med; 2003 Sep; 145(35-36):50-1. PubMed ID: 14584211
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular safety of PDE5 inhibitors.
    Herschorn S
    Can J Urol; 2003 Feb; 10 Suppl 1():23-8. PubMed ID: 12625847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sex, erectile dysfunction, and the heart: a growing problem].
    Görge G; Flüchter S; Kirstein M; Kunz T
    Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Carson CC
    J Urol; 2002 Jul; 168(1):205. PubMed ID: 12073960
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of erectile dysfunction and risk factors for coronary artery disease.
    Kloner RA
    Int J Impot Res; 2005 Dec; 17 Suppl 1():S7-S11. PubMed ID: 16391547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors.
    Jackson G
    Am J Cardiol; 2005 Dec; 96(12B):32M-36M. PubMed ID: 16387564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
    Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
    Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile dysfunction in the cardiac patient.
    Kloner RA
    Curr Urol Rep; 2003 Dec; 4(6):466-71. PubMed ID: 14622500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension.
    Patel MD; Katz SD
    Am J Cardiol; 2005 Dec; 96(12B):47M-51M. PubMed ID: 16387567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract]   [Full Text] [Related]  

  • 19. Erectile dysfunction, sildenafil and cardiovascular risk.
    Chew KK; Stuckey BG; Thompson PL
    Med J Aust; 2000 Mar; 172(6):279-83. PubMed ID: 10860094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
    Reffelmann T; Kloner RA
    Expert Opin Drug Saf; 2005 May; 4(3):531-40. PubMed ID: 15934858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.